Bone Marrow Transplant in India — Advanced Treatment for Blood Cancers & Disorders
Bone marrow transplant (BMT) / haematopoietic stem cell transplant (HSCT) is the treatment of choice for many blood cancers and bone marrow disorders. India has developed dedicated BMT centres with full HLA typing laboratories, clean rooms, and experienced transplant haematologists. Both autologous BMT and allogeneic BMT are performed for conditions including acute and chronic leukaemia, Hodgkin’s and non-Hodgkin’s lymphoma, multiple myeloma, aplastic anaemia, sickle cell disease, and beta-thalassaemia. Post-BMT immunosuppressants are available in India at 60–70% lower cost than in Gulf countries or Europe.
Why India? Key Points
- BMT costs $18,000–$28,000 in India vs $80,000–$200,000 in USA/Germany
- Dedicated BMT units with HEPA-filtered clean rooms and infection control
- Full HLA typing and matched donor registry access
- Autologous and allogeneic (sibling + MUD) transplants available
- Post-BMT immunosuppressants at 60–70% lower cost
- Arabic-speaking coordinators for family support during extended stay
Sub-Treatments Covered
- Autologous Bone Marrow Transplant
- Allogeneic BMT (Sibling)
- Matched Unrelated Donor (MUD) Transplant
- BMT for Leukaemia
- BMT for Lymphoma
- BMT for Aplastic Anaemia
- BMT for Thalassaemia
🏥 Best Hospitals for Bone Marrow Transplant in India
Fortis Memorial Research Institute is a JCI-accredited quaternary-care hospital in Gurgaon, consistently ranked among India's top 5 smart hospitals, handling the country's most complex referral cases in cardiac, neurology, and oncology.
Medanta — The Medicity in Gurgaon is India's highest-ranked private hospital, treating over 20,000 international patients annually from 130 countries, with 1,391 beds and 40 operating theatres across a 43-acre campus.
👨⚕️ Top Bone Marrow Transplant Surgeons in India
Frequently Asked Questions
Autologous BMT: $18,000–$22,000. Allogeneic sibling: $22,000–$28,000. MUD: $28,000–$35,000. USA: $80,000–$250,000.
45–60 days total: 30 days in BMT unit (isolation), then 15–30 days close outpatient monitoring before travel clearance.
Best match: HLA-matched sibling (25% chance per sibling). Otherwise, matched unrelated donor from registry. Haploidentical (half-match) transplants also possible.
Not always. Some leukaemias respond to chemotherapy or targeted therapy alone. Your haematologist determines if BMT is required.
3–4 weeks very low immunity in sterile room. Immune system recovers over 6–12 months. Patients take immunosuppressants and require regular monitoring for 1–2 years.
